2020 US Medicinal Products
Financial Strength Rankings using Artificial Intelligence
| Top rated | 13 of 52 |
| Best rating | 220 % |
| Worst rating | -490 % |
| New companies | 7 |
| Negative Economic Capital Ratio | 17 of 52 |
Financial Strength Rankings using Artificial Intelligence
| Top rated | 13 of 52 |
| Best rating | 220 % |
| Worst rating | -490 % |
| New companies | 7 |
| Negative Economic Capital Ratio | 17 of 52 |
Phoenix Life Sciences International Limited. climbed 29 positions from 43 to 14 due to its excellent Goodwill.MARIMED INC. lost 36 positions from 9 to 45 due to its bad Assets, Current.Cronos Group Inc. entered the 2020 ranking at rank 1, making it the best newcomer.
| Revenues | 37.3 B |
| Assets | 60.1 B |
| Expenses | 36.0 B |
| Stockholders Equity | 24.7 B |
| Unprofitable Companies | 33 of 52 |

This year's rating information is fee-based. Please request rates at
james.woods@realrate.ai